{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease", "multifunctional agent", "quinoline-O-carbamate derivatives", "zebrafish AD model"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36688444", "DateCompleted": {"Year": "2023", "Month": "01", "Day": "24"}, "DateRevised": {"Year": "2023", "Month": "02", "Day": "01"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["2169682", "10.1080/14756366.2023.2169682"], "Journal": {"ISSN": "1475-6374", "JournalIssue": {"Volume": "38", "Issue": "1", "PubDate": {"Year": "2023", "Month": "Dec"}}, "Title": "Journal of enzyme inhibition and medicinal chemistry", "ISOAbbreviation": "J Enzyme Inhib Med Chem"}, "ArticleTitle": "Design, synthesis and evaluation of quinoline-<i>O</i>-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease.", "Pagination": {"StartPage": "2169682", "MedlinePgn": "2169682"}, "Abstract": {"AbstractText": ["A series of novel quinoline-<i>O</i>-carbamate derivatives was rationally designed for treating Alzheimer's disease (AD) by multi-target-directed ligands (MTDLs) strategy. The target compounds were synthesised and evaluated by AChE/BuChE inhibition and anti-inflammatory property. The in\u00a0vitro activities showed that compound <b>3f</b> was a reversible dual <i>ee</i>AChE/eqBuChE inhibitor with IC<sub>50</sub> values of 1.3\u2009\u00b5M and 0.81\u2009\u00b5M, respectively. Moreover, compound <b>3f</b> displayed good anti-inflammatory property by decreasing the production of IL-6, IL-1\u03b2 and NO. In addition, compound <b>3f</b> presented significant neuroprotective effect on A<i>\u03b2</i><sub>25-35</sub>-induced PC12 cell injury. Furthermore, compound <b>3f</b> presented good stabilities in artificial gastrointestinal fluids, liver microsomes <i>in\u00a0vitro</i> and plasma. Furthermore, compound <b>3f</b> could improve AlCl<sub>3</sub>-induced zebrafish AD model by increasing the level of ACh. Therefore, compound <b>3f</b> was a promising multifunctional agent for the treatment of AD."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Inner Mongolia Key Laboratory of Toxicant Monitoring and Toxicology, College of Animal Science and Technology, Inner Mongolia Minzu University, Tongliao, Inner Mongolia, China."}], "LastName": "Chen", "ForeName": "Hongsong", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang, Henan, China."}], "LastName": "Mi", "ForeName": "Jing", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopaedics Surgery, Nanyang Central Hospital, Nanyang, Henan, China."}], "LastName": "Li", "ForeName": "Sen", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang, Henan, China."}], "LastName": "Liu", "ForeName": "Zhengwei", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang, Henan, China."}], "LastName": "Yang", "ForeName": "Jing", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, Guizhou, China."}], "LastName": "Chen", "ForeName": "Rui", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, Guizhou, China."}], "LastName": "Wang", "ForeName": "Yujie", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, Guizhou, China."}], "LastName": "Ban", "ForeName": "Yujuan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang, Henan, China."}], "LastName": "Zhou", "ForeName": "Yi", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Inner Mongolia Key Laboratory of Toxicant Monitoring and Toxicology, College of Animal Science and Technology, Inner Mongolia Minzu University, Tongliao, Inner Mongolia, China."}], "LastName": "Dong", "ForeName": "Wu", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang, Henan, China."}, {"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Hainan University, Haikou, Hainan, China."}], "LastName": "Sang", "ForeName": "Zhipei", "Initials": "Z"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Enzyme Inhib Med Chem", "NlmUniqueID": "101150203", "ISSNLinking": "1475-6366"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Amyloid beta-Peptides"}, {"RegistryNumber": "0", "NameOfSubstance": "Carbamates"}, {"RegistryNumber": "0", "NameOfSubstance": "Cholinesterase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Hydroxyquinolines"}, {"RegistryNumber": "0", "NameOfSubstance": "Quinolines"}, {"RegistryNumber": "EC 3.1.1.7", "NameOfSubstance": "Acetylcholinesterase"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": [], "DescriptorName": "Amyloid beta-Peptides"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Carbamates"}, {"QualifierName": [], "DescriptorName": "Zebrafish"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Cholinesterase Inhibitors"}, {"QualifierName": [], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": [], "DescriptorName": "Hydroxyquinolines"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Quinolines"}, {"QualifierName": [], "DescriptorName": "Drug Design"}, {"QualifierName": ["metabolism"], "DescriptorName": "Acetylcholinesterase"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}], "CoiStatement": "The authors report no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, Cummings J, van der Flier WM.. Alzheimer\u2019s disease. Lancet. 2021;397(10284):1577\u20131590.", "ArticleIdList": ["PMC8354300", "33667416"]}, {"Citation": "Alzheimer\u2019s Disease International . World Alzheimer report 2019: attitudes to dementia. London: Alzheimer\u2019s Disease International; 2019. p. 1\u201313 [accessed 2019 Sep]. Available from: https://www.alz.co.uk/research/world-report-2019."}, {"Citation": "Barnett R. Alzheimer\u2019s disease. Lancet. 2019;393(10181):1589.", "ArticleIdList": ["31007191"]}, {"Citation": "Cummings J, Lee G, Zhong K, Fonseca J, Taghva K.. Alzheimer\u2019s disease drug development pipeline: 2021. Alzheimers Dement. 2021;7(1):e12179.", "ArticleIdList": ["PMC8145448", "34095440"]}, {"Citation": "Sang Z, Wang K, Dong J, Tang L.. Alzheimer\u2019s disease: updated multi-targets therapeutics are in clinical and in progress. Eur J Med Chem. 2022;238:114464.", "ArticleIdList": ["35635955"]}, {"Citation": "Zhang H, Wang Y, Wang Y, Li X, Wang S, Wang Z.. Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer\u2019s disease. Eur J Med Chem. 2022;240:114606.", "ArticleIdList": ["35858523"]}, {"Citation": "Hampel H, Mesulam MM, Cuello AC, Farlow MR, Giacobini E, Grossberg GT, Khachaturian AS, Vergallo A, Cavedo E, Snyder PJ, Khachaturian ZS.. The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease. Brain. 2018;141(7):1917\u20131933.", "ArticleIdList": ["PMC6022632", "29850777"]}, {"Citation": "Francis PT. The interplay of neurotransmitters in Alzheimer\u2019s\u2002disease. CNS Spectr. 2005;10(11 Suppl 18):6\u20139.", "ArticleIdList": ["16273023"]}, {"Citation": "Inestrosa NC, Urra S, Colombres M.. Acetylcholinesterase (AChE)\u2013amyloid-beta-peptide complexes in Alzheimer\u2019s disease. the Wnt signaling pathway. Curr Alzheimer Res. 2004;1(4):249\u2013254.", "ArticleIdList": ["15975054"]}, {"Citation": "Li Q, Yang H, Chen Y, Sun H.. Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer\u2019s disease. Eur J Med Chem. 2017;132:294\u2013309.", "ArticleIdList": ["28371641"]}, {"Citation": "Jasiecki J, Targo\u0144ska M, Was\u0105g B.. The role of butyrylcholinesterase and iron in the regulation of cholinergic network and cognitive dysfunction in Alzheimer\u2019s disease pathogenesis. Int J Mol Sci. 2021;22(4):2033.", "ArticleIdList": ["PMC7922581", "33670778"]}, {"Citation": "Forloni G, Balducci C.. Alzheimer\u2019s disease, oligomers, and inflammation. J Alzheimers Dis. 2018;62(3):1261\u20131276.", "ArticleIdList": ["PMC5869993", "29562537"]}, {"Citation": "Ozben T, Ozben S.. Neuro-inflammation and anti-inflammatory treatment options for Alzheimer\u2019s disease. Clin Biochem. 2019;72:87\u201389.", "ArticleIdList": ["30954437"]}, {"Citation": "Liu P, Wang Y, Sun Y, Peng G.. Neuroinflammation as a potential therapeutic target in Alzheimer\u2019s disease. Clin Interv Aging. 2022;17:665\u2013674.", "ArticleIdList": ["PMC9064449", "35520949"]}, {"Citation": "Moor LFE, Vasconcelos TRA, da R Reis R, Pinto LSS, da Costa TM.. Quinoline: an attractive scaffold in drug design. Mini Rev Med Chem. 2021;21(16):2209\u20132226.", "ArticleIdList": ["33568032"]}, {"Citation": "Tabassum R, Ashfaq M, Oku H.. Current pharmaceutical aspects of synthetic quinoline derivatives. Mini Rev Med Chem. 2021;21(10):1152\u20131172.", "ArticleIdList": ["33319670"]}, {"Citation": "Yang X, Cai P, Liu Q, Wu J, Yin Y, Wang X, Kong L.. Novel 8-hydroxyquinoline derivatives targeting \u03b2-amyloid aggregation, metal chelation and oxidative stress against Alzheimer\u2019s disease. Bioorg Med Chem. 2018;26(12):3191\u20133201.", "ArticleIdList": ["29729985"]}, {"Citation": "Pavlidis N, Kofinas A, Papanikolaou MG, Miras HN, Drouza C, Kalampounias AG, Kabanos TA, Konstandi M, Leondaritis G.. Synthesis, characterization and pharmacological evaluation of quinoline derivatives and their complexes with copper(\u0399\u0399) in in\u00a0vitro cell models of Alzheimer\u2019s disease. J Inorg Biochem. 2021;217:111393.", "ArticleIdList": ["33610031"]}, {"Citation": "Wang XQ, Zhao CP, Zhong LC, Zhu DL, Mai DH, Liang MG, He MH.. Preparation of 4-flexible amino-2-arylethenyl-quinoline derivatives as multi-target agents for the treatment of Alzheimer\u2019s disease. Molecules. 2018;23(12):3100.", "ArticleIdList": ["PMC6321145", "30486440"]}, {"Citation": "Wang Z, Hu J, Yang X, Feng X, Li X, Huang L, Chan ASC.. Design, synthesis, and evaluation of orally bioavailable quinoline-indole derivatives as innovative multitarget-directed ligands: promotion of cell proliferation in the adult murine hippocampus for the treatment of Alzheimer\u2019s disease. J Med Chem. 2018;61(5):1871\u20131894.", "ArticleIdList": ["29420891"]}, {"Citation": "Nguyen K, Hoffman H, Chakkamparambil B, Grossberg GT.. Evaluation of rivastigmine in Alzheimer\u2019s disease. Neurodegener Dis Manag. 2021;11(1):35\u201348.", "ArticleIdList": ["33198569"]}, {"Citation": "Sang Z, Bai P, Ban Y, Wang K, Wu A, Mi J, Hu J, Xu R, Zhu G, Wang J, et al. . Novel donepezil-chalcone-rivastigmine hybrids as potential multifunctional anti-Alzheimer\u2019s agents: design, synthesis, in\u00a0vitro biological evaluation, in\u00a0vivo and in silico studies. Bioorg Chem. 2022;127:106007.", "ArticleIdList": ["35849893"]}, {"Citation": "Sang Z, Wang K, Bai P, Wu A, Shi J, Liu W, Zhu G, Wang Y, Lan Y, Chen Z, et al. . Design, synthesis and biological evaluation of novel O-carbamoyl ferulamide derivatives as multi-target-directed ligands for the treatment of Alzheimer\u2019s disease. Eur J Med Chem. 2020;194:112265.", "ArticleIdList": ["32240904"]}, {"Citation": "Sang Z, Wang K, Shi J, Liu W, Tan Z.. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer\u2019s disease. Eur J Med Chem. 2019;178:726\u2013739.", "ArticleIdList": ["31229875"]}, {"Citation": "Mesiti F, Chavarria D, Gaspar A, Alcaro S, Borges F.. The chemistry toolbox of multitarget-directed ligands for Alzheimer\u2019s disease. Eur J Med Chem. 2019;181:111572.", "ArticleIdList": ["31404859"]}, {"Citation": "Sang Z, Wang K, Shi J, Liu W, Cheng X, Zhu G, Wang Y, Zhao Y, Qiao Z, Wu A, et al. . The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer\u2019s disease. Eur J Med Chem. 2020;192:112180.", "ArticleIdList": ["32131034"]}, {"Citation": "Sang Z, Qiang X, Li Y, Yuan W, Liu Q, Shi Y, Ang W, Luo Y, Tan Z, Deng Y.. Design, synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer\u2019s disease. Eur J Med Chem. 2015;94:348\u2013366.", "ArticleIdList": ["25778991"]}, {"Citation": "Tian C, Qiang X, Song Q, Cao Z, Ye C, He Y, Deng Y, Zhang L.. Flurbiprofen-chalcone hybrid Mannich base derivatives as balanced multifunctional agents against Alzheimer\u2019s disease: design, synthesis and biological evaluation. Bioorg Chem. 2020;94:103477.", "ArticleIdList": ["31818478"]}, {"Citation": "Erdogan M, Kilic B, Sagkan RI, Aksakal F, Ercetin T, Gulcan HO, Dogruer DS.. Design, synthesis and biological evaluation of new benzoxazolone/benzothiazolone derivatives as multi-target agents against Alzheimer\u2019s disease. Eur J Med Chem. 2021;212:113124.", "ArticleIdList": ["33395623"]}, {"Citation": "Ko\u0161ak U, Brus B, Knez D, \u017dakelj S, Trontelj J, Pi\u0161lar A, \u0160ink R, Juki\u010d M, \u017divin M, Podkowa A, Nachon F, et al. . The magic of crystal structure-based inhibitor optimization: development of a butyrylcholinesterase inhibitor with picomolar affinity and in\u00a0vivo activity. J Med Chem. 2018;61(1):119\u2013139.", "ArticleIdList": ["29227101"]}, {"Citation": "Dighe SN, Deora GS, De la Mora E, Nachon F, Can S, Parat MO, Brazzolotto X, Ross BP.. Discovery and structure-activity relationships of a highly selective butyrycholinesterase inhibitor by structure-based virtual screening. J Med Chem. 2016;59:7683\u20137689.", "ArticleIdList": ["27405689"]}, {"Citation": "Liu Z, Fang L, Zhang H, Gou S, Chen L.. Design, synthesis and biological evaluation of multifunctional tacrine-curcumin hybrids as new cholinesterase inhibitors with metal ions-chelating and neuroprotective property. Bioorg Med Chem. 2017;25(8):2387\u20132398.", "ArticleIdList": ["28302511"]}, {"Citation": "Wu CF, Wang QC, Chen R, Zhou HL, Wu TT, Du Y, Zhang NN, Zhang HM, Fan ZY, Wang LL, et al. . Synthesis and bioevaluation of diaryl urea derivatives as potential antitumor agents for the treatment of human colorectal cancer. Eur J Med Chem. 2022;229:114055.", "ArticleIdList": ["34971874"]}, {"Citation": "Huang W, Li C, Shen Z, Zhu X, Xia B, Li C.. Development of a zebrafish model for rapid drug screening against Alzheimer\u2019s disease. J Pharm Pharmacol. 2016;4:174\u2013185."}, {"Citation": "Sang Z, Wang K, Xue H, Cao M, Tan Z, Liu W.. Design, synthesis and evaluation of novel ferulic acid derivatives as multi-target-directed ligands for the treatment of Alzheimer\u2019s disease. ACS Chem Neurosci. 2019;10(2):1008\u20131024.", "ArticleIdList": ["30537804"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "1", "Day": "23", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "1", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "23"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36688444", "PMC9873282", "10.1080/14756366.2023.2169682"]}}], "PubmedBookArticle": []}